A tandem repeat of MUC1 core protein induces a weak in vitro immune response in human B cells

Cancer Immunology Immunotherapy

Volumn 47, Issue 5, 1999, Pages 249-256

  Andersson, Eva ^a   Henderikx, Paula ^b   Krambovitis, Elias ^c   Hoogenboom, Hennie R ^b   Borrebaeck, Carl A K ^a  

^a LUND UNIVERSITY   (Sweden)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

Author keywords

Carcinoma; Human antibodies; In vitro immunization; MUC1; Phage display

Indexed keywords

AUTOANTIGEN; CORE PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; MUCIN;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; TANDEM REPEAT;

AMINO ACID SEQUENCE; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; MOLECULAR SEQUENCE DATA; MUCINS; TANDEM REPEAT SEQUENCES;

EID: 0032892162     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050528     Document Type: Article

References (46)

1. 1. Agrawal B, Krantz MJ, Reddish MA, Longenecker BM (1998) Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat Med 4:43
2. 2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patients. Int J Cancer [Suppl]:89
3. 3. Barratt-Boyes SM (1996) Making the most of mucin: a novel target for tumor immunotherapy. Cancer Immunol Immunother 43:142
4. 4. Berruti A, Tampellini M, Torta M, Buniva T, Gorzegno G, Dogliotti L (1994) Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease. Eur J Cancer 30A:2082
5. 5. Burchell J, Taylor-Papadimitriou J (1993) Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product. Epithelial Cell Biol 2:155
6. 6. Burchell J, Gendler S, Taylor-Papadimitriou J, Girling A, Lewis A, Millis R, Lamport D (1987) Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 47:5476
7. 7. Burchell J, Taylor-Papadimitriou J, Boshell M, Gendler S, Duhig T (1989) A short sequence, within the aminoacid tandem repeat of a cancer-associated mucin, cotains immunodominant epitopes. Int J Cancer 44:691
8. 8. Chin L-T, Hinkula J, Levi M, Ohlin M, Wahren B, Borrebaeck CAK (1994) Site-directed primary in vitro immunization: production of HIV-1 neutralising human monoclonal antibodies from lymphocytes obtained from seronegative donors. Immunology 81:428
9. 9. Chin L-T, Malmborg A-C, Kristensson K, Hinkula J, Wahren B, Borrebaeck CAK (1995) Mimicking the humoral immune response in vitro results in antigen specific isotype switching supported by specific autologous T helper cells: generation of human HIV-1 neutralising IgG monoclonal antibodies from naive donors. Eur J Immunol 25:657
10. 10. Chomczynski P, Sacchi N (1997) Current protocols in molecular biology, chapter 4. Wiley, New York
11. 11. Coventry BJ, Weeks SC, Heckford SE, Sykes PJ, Bradley J, Skinner JM (1996) Lack of IL-2 cytokine expression despite IL-2 messenger RNA transcription in tumour-infiltrating lymphocytes in primary human breast carcinoma. J Immunol 156:3486
12. 12. DeNardo SJ, Kramer EL, O'Donnell RT, Richman CM, Salako QA, Shen S, Noz M, Glenn SD, Ceriani RL, DeNardo GL (1997) Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial. J Nucl Med 38:1180
13. 13. Dueñas M, Chin L-T, Malmborg A-C, Casalvilla R, Ohlin M, Borrebaeck CAK (1996) In vitro immunization of naive hũ man B cells yields high affinity immunoglobulin G antibodies as illustrated by phage display. Immunology 89:1
14. 14. Finn OJ, Gendler SJ (1998) Mimic 1 of MUC1. Nat Biotechnol 16:236
15. 15. Finn OJ, Jerome KR, Henderson RA, Pecher G, Domenech N, Magarian-Blander J, Barratt-Boyes SM (1995) MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 145:61
16. 16. Fontenot JD, Mariappan SVS, Catasti P, Domenech N, Finn OJ, Gupta G (1995) Structure of a tumor associated antigen containing a tandemly repeated immunodominant epitope. J Biomol Struct Dyn 13:245
17. 17. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J, Pemberton L, Lalani EN, Wilson D (1990) Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 265:15286
18. 18. Gimmi CD, Morrison BW, Mainprice BA, Gribben JG, Boussiotis VA, Freeman GJ, Park SY, Watanabe M, Gong J, Hayes DF, Kufe DW, Nadler LM (1996) Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nat Med 2:1367
19. 19. Gourevitch MM, von Mensdorff-Pouilly S, Litvinov SV, Kenemans P, van Kamp GJ, Verstraeten AA, Hilgers J (1995) Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. Br J Cancer 72:934
20. 20. Granowska M, Britton KE, Mather SJ, Lowe DG, Ellison D, Bomanji J, Burchell J, Taylor-Papadimitriou J, Hudson CR, Shepherd JH (1993) Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer. Eur J Nucl Med 20:483
21. 21. Hawkins RE, Russell SJ, Winter G (1992) Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol 226:889
22. 22. Henderikx P, Kandilogiannaki M, Petrarca C, von Mensdorff-Pouilly S, Hilgers JHM, Krambovitis E, Arends JW, Hoogenboom HR (1998) Human scFv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma. Cancer Res 58:4324
23. 23. Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS (1993) Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 53:641
24. 24. Keohavong P, Thilly WG (1989) Fidelity of DNA polymerases in DNA amplification. Proc Natl Acad Sci USA 86:9253
25. 25. Kotera Y, Fontenot JD, Pecher G, Metzgar RS, Finn OJ (1994) Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic and colon cancer patients. Cancer Res 54:2856
26. 26. Kotera Y, Fontenot JD, Pecher G, Metzgar RS, Finn OJ (1994) Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res 54:2856
27. 27. Krambovitis E, Xatzidakis G, Barlos K (1998) Preparation of MUC-1 oligomers using an improved convergent solid-phase peptide synthesis. J Biol Chem (in press)
28. 28. Kunkler RB, Bishop MC, Green DJ, Pimm MV, Price MR, Frier M (1995) Targeting of bladder cancer with monoclonal antibody NCRC48 - a possible approach for intravesical therapy. Br J Urol 76:81
29. 29. Lloyd KO, Burchell J, Kudryashov V, Yin BWT, Taylor-Papadimitriou J (1996) Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. J Biol Chem 52:33325
30. 30. MacLennan IC (1994) Germinal centers. Annu Rev Immunol 12:117
31. 31. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G (1991) By-passing immunization: human antibodies from V-gene libraries displayed on phage. J Mol Biol 222:581
32. 32. Martoni A, Zamagni C, Bellanova B, Zanichelli L, Vecchi F, Cacciari N, Strocchi E, Pannuti F (1995) CEA, MCA, CA 15.3 and CA 549 and their combinations in expressing and monitoring metastatic breast cancer: a prospective comparative study. Eur J Cancer 31A:1615
33. 33. Mensdorff-Pouilly S von, Gourevitch MM, Kenemans P, Verstraeten AA, Litvinov SV, Kamp GJ van, Meijer S, Vermorken J, Hilgers J (1996) Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. Eur J Cancer 32A:1325
34. 34. Mensdorff-Pouilly S von, Gourevitch M, Kenemans P, Verstraeten A, Kamp G van, Kok A, Uffelen K van, Snijdewint F, Paul M, Meijer S, Hilgers J (1998) An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1). Tumour Biol 19:186
35. 35. Ohlin M, Borrebaeck CAK (1993) Production of human monoclonal antibodies. In: Masseyeff RF, Albert WHF, Staines NA (eds) Methods of immunological analysis VCH, Weinheim, p 298
36. 36. Ohlin M, Owman H, Mach M, Borrebaeck CAK (1996) Light chain shuffling of a high affinity antibody results in a drift in epitope recognition. Mol Immunol 33:47
37. 37. Petrarca C, Rughetti A, Rahimi H, D'Agostini F, Turchi V, Apollonj Ghetti C, Scambia G, Frati L, Nuti M (1996) Human antibodies against the polymorphic epithelial mucin in ovarian cancer patients recognise a novel sequence in the tandem repeat region. Eur J Cancer 32A:12
38. 38. Regimbald LH, Pilarski LM, Longenecker BM, Reddish MA, Zimmermann G, Hugh JC (1996) The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Res 56:4244
39. 39. Roussel P, Lamblin G, Lhermitte M, Houdret N, Laffitte J-J, Perini J-M, Klein A, Scharfman A (1988) The complexity of mucins. Biochimie 70:1471
40. 40. Simonsson Lagerkvist AC, Furebring C Borrebaeck CAK (1995) Single, antigen-specific b cells used to generate Fab fragments using CD40-mediated amplification or direct PCR cloning. Biotechniques 18:862
41. 41. Söderlind E, Simonsson-Lagerkvist AC, Dueñas M, Malmborg AC, Ayala M, Danielsson L, Borrebaeck CAK (1993) Chaperonin assisted phage display of antibody fragments on filamentous bacteriophages. Biotechnology 11:503
42. 42. Tindall KR, Kunkel TA (1988) Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase. Biochemistry 27:6008
43. 43. Valmori D, Sabbatini A, Lanzavecchia A, Corradin G, Matricardi PM (1994) Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles. J Immunol 152:2921
44. 44. Wagner S, Neuberger MS (1996) Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol 14:441
45. 45. Zafiropoulos A, Andersson E, Krambovitis E, Borrebaeck CAK (1997) Induction of antigen-specific isotype switching by in vitro immunization of human naive B lymphocytes. J Immunol Methods 200:181
46. 46. Zotter S, Hageman P, Lossnitzer A, Mooi WJ, Hilgers J (1988) Tissue and tumour distribution of human polymorphic epithelial mucin. Cancer Rev 11-12:56